Male Breast Cancer Survival Rates Lag Behind Women's

Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer cases. Despite advances in breast cancer detection and treatment, men diagnosed with breast cancer generally have lower survival rates than women. Studies show that 5-year overall survival rates for men are around 77.6%, compared to 86.4% for women, highlighting a significant survival gap1 2. This disparity underscores the need for better understanding and targeted approaches to improve outcomes for men with breast cancer.

Stagnant Survival Rates Over Three Decades

Over the past 30 years, survival rates for male breast cancer have remained largely unchanged. Population-based studies analyzing data from large registries such as SEER (Surveillance, Epidemiology, and End Results) reveal that male breast cancer-specific survival has been stable, with no significant improvement across different stages of the disease3 4. In contrast, female breast cancer survival has steadily improved due to advances in early detection and treatment3 .

A matched-pair study involving 434 male breast cancer patients and female counterparts showed a median follow-up of 10 years but found no significant survival improvement for men over time5 . The slight gains observed in overall survival for men are attributed more to increasing life expectancy rather than cancer-specific factors3 4.

Data from the United States between 2007 and 2016 indicate that the 5-year relative survival rate for men with breast cancer is approximately 84.7%, with survival varying significantly by stage at diagnosis: 98.7% for localized disease, 83.7% for regional spread, and only 25.9% for distant metastases6 . These figures have remained consistent over the decades, emphasizing the need for improved strategies tailored to male patients.

The lack of progress in male breast cancer survival contrasts sharply with the advances seen in female breast cancer, where routine mammography screening and targeted therapies have contributed to improved outcomes3 6.

Dedicated studies are needed to better understand the biology of male breast cancer and improve outcomes for men with the disease8 .

Factors Contributing to Lower Male Survival

Several factors contribute to the lower survival rates observed in men with breast cancer compared to women. These include delayed diagnosis, less aggressive treatment, biological differences, and limited awareness.

• Delayed Diagnosis: Men often present with more advanced disease stages because there is no routine screening mammography for men, unlike women who benefit from regular screening programs3 7. Detection in men usually relies on palpable symptoms such as a subareolar mass, nipple changes, or skin alterations, which often indicate later-stage disease3 7. Lower awareness among both the public and healthcare providers contributes to diagnostic delays7 .

• Less Aggressive Treatment: Treatment for male breast cancer tends to be less aggressive than for female breast cancer. Physicians may be less confident managing male breast cancer due to its rarity and the lack of male-specific clinical trial data3 7. Some therapies effective in women may have different pharmacologic responses in men, affecting treatment efficacy7 . This undertreatment has been linked to higher mortality rates in men8 9.

• Biological and Clinical Differences: Male breast cancer is typically diagnosed at an older median age (~68 years) compared to women and is often hormone receptor-positive, which influences treatment options3 10. Despite similarities, men with breast cancer have a 19% higher chance of dying within 5 years of diagnosis than women, even after adjusting for clinical factors such as tumor type, stage, and treatment8 9.

• Survival Disparities by Race and Region: Survival rates vary by race, ethnicity, and geographic region. For example, Black men have lower 5-year relative survival (77.6%) compared to White men (86.0%) 6. These disparities reflect broader socioeconomic and healthcare access issues11 12.

• Long-Term Mortality Risk: Men with hormone receptor-positive breast cancer face a persistent risk of breast cancer-specific mortality for at least 20 years after diagnosis, with higher risks associated with younger age and more advanced stage at diagnosis13 .

These factors collectively contribute to the survival gap between men and women with breast cancer.

Men with breast cancer have often been grouped with women in clinical trials and evaluations, which may limit understanding of male-specific disease characteristics and outcomes8 .

Male Breast Cancer Support Resources

Support resources for men with breast cancer are limited compared to those available for women. This scarcity contributes to feelings of isolation and may impact emotional well-being and treatment adherence.

Other known or suspected contributors to the disparity in death rates, such as compliance to cancer treatment, tumor genetics, and lifestyle factors including obesity, smoking, and alcohol use, have not been fully investigated8 .

• Under-Recognition and Awareness: Male breast cancer is rare and often under-recognized, leading to delayed diagnosis and treatment3 7. Increased public and provider education is critical to improve early detection and awareness7 .

• Psychosocial Support: Men with breast cancer frequently report feelings of isolation due to the female-centric nature of breast cancer advocacy and support groups7 14. Male-focused support organizations provide community and promote research tailored to male patients7 .

• Importance of Peer Support: Peer support groups are essential for emotional well-being and can help men cope with the psychological distress associated with breast cancer diagnosis and treatment7 15.

More studies focusing specifically on men with breast cancer are needed to understand why their outcomes differ from those of women8 .

• Need for Tailored Resources: Given the unique challenges faced by men, including older age at diagnosis and different treatment responses, dedicated resources and support networks are necessary to address their specific needs7 14.

• Increase awareness campaigns targeting men and healthcare providers7 .

• Develop and promote male-specific support groups and advocacy organizations7 .
• Provide education on recognizing symptoms and the importance of early diagnosis3 .
• Encourage inclusion of men in breast cancer clinical trials to improve treatment data8 .
• Enhance psychosocial support services tailored to male patients15 .

Expanding these resources can help bridge the gap in survival outcomes by promoting earlier diagnosis, better treatment adherence, and improved quality of life for men with breast cancer.